Abstract
Bacillus Calmette-Guerin has been established as one of the most active agents for the treatment of superficial transitional cell carcinoma of the bladder. Although complications do occur with this agent, they are usually transient and mild. Two cases are herein reported in which dystrophic calcification of the urinary bladder occurred following BCG therapy; one had a diffuse and severe complication. This complication can occur with other intravesical agents, and methods for management are reported.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 89-92 |
| Number of pages | 4 |
| Journal | Urology |
| Volume | 42 |
| Issue number | 1 |
| DOIs | |
| State | Published - 1993 |
Fingerprint
ASJC Scopus subject areas
- Urology
Cite this
Dystrophic bladder wall calcifications following intravesical BCG treatment for superficial transitional cell carcinoma of bladder. / Spirnak, Joseph E.; Lubke, William L.; Thompson, Ian M.; Lopez, Milagros.
In: Urology, Vol. 42, No. 1, 1993, p. 89-92.Research output: Contribution to journal › Article
}
TY - JOUR
T1 - Dystrophic bladder wall calcifications following intravesical BCG treatment for superficial transitional cell carcinoma of bladder
AU - Spirnak, Joseph E.
AU - Lubke, William L.
AU - Thompson, Ian M.
AU - Lopez, Milagros
PY - 1993
Y1 - 1993
N2 - Bacillus Calmette-Guerin has been established as one of the most active agents for the treatment of superficial transitional cell carcinoma of the bladder. Although complications do occur with this agent, they are usually transient and mild. Two cases are herein reported in which dystrophic calcification of the urinary bladder occurred following BCG therapy; one had a diffuse and severe complication. This complication can occur with other intravesical agents, and methods for management are reported.
AB - Bacillus Calmette-Guerin has been established as one of the most active agents for the treatment of superficial transitional cell carcinoma of the bladder. Although complications do occur with this agent, they are usually transient and mild. Two cases are herein reported in which dystrophic calcification of the urinary bladder occurred following BCG therapy; one had a diffuse and severe complication. This complication can occur with other intravesical agents, and methods for management are reported.
UR - http://www.scopus.com/inward/record.url?scp=0027304933&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0027304933&partnerID=8YFLogxK
U2 - 10.1016/0090-4295(93)90350-J
DO - 10.1016/0090-4295(93)90350-J
M3 - Article
VL - 42
SP - 89
EP - 92
JO - Urology
JF - Urology
SN - 0090-4295
IS - 1
ER -